BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32327728)

  • 1. Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.
    Packiriswamy N; Upreti D; Zhou Y; Khan R; Miller A; Diaz RM; Rooney CM; Dispenzieri A; Peng KW; Russell SJ
    Leukemia; 2020 Dec; 34(12):3310-3322. PubMed ID: 32327728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
    Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
    Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma.
    Dispenzieri A; Tong C; LaPlant B; Lacy MQ; Laumann K; Dingli D; Zhou Y; Federspiel MJ; Gertz MA; Hayman S; Buadi F; O'Connor M; Lowe VJ; Peng KW; Russell SJ
    Leukemia; 2017 Dec; 31(12):2791-2798. PubMed ID: 28439108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
    Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virotherapy: A Contest between Apples and Oranges.
    Russell SJ; Peng KW
    Mol Ther; 2017 May; 25(5):1107-1116. PubMed ID: 28392162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
    Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
    Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers.
    Liu C; Russell SJ; Peng KW
    Mol Ther; 2010 Jun; 18(6):1155-64. PubMed ID: 20234340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of disseminated cancer after systemic oncolytic virotherapy.
    Russell SJ; Federspiel MJ; Peng KW; Tong C; Dingli D; Morice WG; Lowe V; O'Connor MK; Kyle RA; Leung N; Buadi FK; Rajkumar SV; Gertz MA; Lacy MQ; Dispenzieri A
    Mayo Clin Proc; 2014 Jul; 89(7):926-33. PubMed ID: 24835528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.
    Li H; Peng KW; Russell SJ
    Hum Gene Ther; 2012 Mar; 23(3):295-301. PubMed ID: 22235810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.
    Myers RM; Greiner SM; Harvey ME; Griesmann G; Kuffel MJ; Buhrow SA; Reid JM; Federspiel M; Ames MM; Dingli D; Schweikart K; Welch A; Dispenzieri A; Peng KW; Russell SJ
    Clin Pharmacol Ther; 2007 Dec; 82(6):700-10. PubMed ID: 17971816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
    Msaouel P; Dispenzieri A; Galanis E
    Curr Opin Mol Ther; 2009 Feb; 11(1):43-53. PubMed ID: 19169959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).
    Opyrchal M; Allen C; Iankov I; Aderca I; Schroeder M; Sarkaria J; Galanis E
    Hum Gene Ther; 2012 Apr; 23(4):419-27. PubMed ID: 22185260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.
    Dingli D; Peng KW; Harvey ME; Greipp PR; O'Connor MK; Cattaneo R; Morris JC; Russell SJ
    Blood; 2004 Mar; 103(5):1641-6. PubMed ID: 14604966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.
    Engeland CE; Grossardt C; Veinalde R; Bossow S; Lutz D; Kaufmann JK; Shevchenko I; Umansky V; Nettelbeck DM; Weichert W; Jäger D; von Kalle C; Ungerechts G
    Mol Ther; 2014 Nov; 22(11):1949-59. PubMed ID: 25156126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.
    Li H; Peng KW; Dingli D; Kratzke RA; Russell SJ
    Cancer Gene Ther; 2010 Aug; 17(8):550-8. PubMed ID: 20379224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.
    Msaouel P; Iankov ID; Allen C; Aderca I; Federspiel MJ; Tindall DJ; Morris JC; Koutsilieris M; Russell SJ; Galanis E
    Mol Ther; 2009 Dec; 17(12):2041-8. PubMed ID: 19773744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.
    Galanis E; Atherton PJ; Maurer MJ; Knutson KL; Dowdy SC; Cliby WA; Haluska P; Long HJ; Oberg A; Aderca I; Block MS; Bakkum-Gamez J; Federspiel MJ; Russell SJ; Kalli KR; Keeney G; Peng KW; Hartmann LC
    Cancer Res; 2015 Jan; 75(1):22-30. PubMed ID: 25398436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.
    Peng KW; Dogan A; Vrana J; Liu C; Ong HT; Kumar S; Dispenzieri A; Dietz AB; Russell SJ
    Am J Hematol; 2009 Jul; 84(7):401-7. PubMed ID: 19507209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic virotherapy for multiple myeloma.
    Stief AE; McCart JA
    Expert Opin Biol Ther; 2008 Apr; 8(4):463-73. PubMed ID: 18352850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.